Page 9 - Lipocine Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lipocine (NASDAQ:LPCN) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.24 on Tuesday. Lipocine has a 1 year low of $3.30 and a […]

Maheshv patelBlackrock incEp wealth advisorsLipocine incRenaissance technologiesSecurities exchange commissionTopco ltdFree reportGet free reportExchange commissionStreet corpLipocine dailyNasdaq lpcnInitiated coverageStocknews com

Lipocine (NASDAQ:LPCN) Research Coverage Started at StockNews com

Lipocine (NASDAQ:LPCN) Research Coverage Started at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Maheshv patelBlackrock incRenaissance technologiesEp wealth advisorsBailard incWealthspan partnersLipocine incFree reportStock downGet free reportLipocine daily

Lipocine Inc to Post FY2024 Earnings of ($2 43) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:LPCN)

Lipocine Inc to Post FY2024 Earnings of ($2 43) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:LPCN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Maheshv patelBlackrock incLipocine incTopco ltdCantor fitzgeraldSecurities exchange commissionRenaissance technologiesEp wealth advisorsFree reportGet free reportTrading downStreet corpExchange commissionLipocine daily

Lipocine (NASDAQ:LPCN) Now Covered by StockNews com

StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report report published on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 0.7 % Shares of NASDAQ:LPCN opened at $4.42 on Monday. The company has a market capitalization of $22.98 million, a […]

Maheshv patelEp wealth advisorsRenaissance technologiesTopco ltdLipocine company profileLipocine incBlackrock incFree reportGet free reportStreet corpLipocine daily

StockNews com Begins Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Monday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $4.42 on Monday. Lipocine has a 1 year low of $3.30 and a 1 year high of $14.28. The […]

Maheshv patelBailard incLipocine company profileLipocine incGoldman sachs group incWealthspan partnersRenaissance technologiesTopco ltdFree reportGet free reportGoldman sachs groupSachs groupLipocine dailyNasdaq lpcnInitiated coverageStocknews com